HUIZENGA THEODORE ALAN (SVP, Chief Accounting Officer) reported 1 transaction at ULTRAGENYX PHARMACEUTICAL INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/11/2024ACC: 0000950170-24-135525
Officer· SVP, Chief Accounting Officer
Since Mar 2026
-648.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
648.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−648.00
Price / share
—
Trade value
—
% of position
1.5%
12/10/2024
42.49K→41.84K
Total
Net shares
−648.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/10/2024 | G · Gift | −648.00 | — | — | 1.5% | 42.49K | 41.84K |
| Total | −648.00 | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported